Paroxysmal Nocturnal Hemoglobinuria Drugs and Forecast - Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs
1.2 Key Market Segments
1.2.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Segment by Type
1.2.2 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Competitive Landscape
3.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Manufacturers (2019-2024)
3.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Sites, Area Served, Product Type
3.6 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Competitive Situation and Trends
3.6.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Industry Chain Analysis
4.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share by Type (2019-2024)
6.3 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Price by Type (2019-2024)
7 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Sales by Application (2019-2024)
7.3 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Growth Rate by Application (2019-2024)
8 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Consumption by Region
8.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Region
8.1.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Region
8.1.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Production by Region
9.1 Global Production of Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs by Region (2019-2024)
9.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Revenue Market Share by Region (2019-2024)
9.3 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production
9.4.1 North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production Growth Rate (2019-2024)
9.4.2 North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production
9.5.1 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production Growth Rate (2019-2024)
9.5.2 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production (2019-2024)
9.6.1 Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production Growth Rate (2019-2024)
9.6.2 Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production (2019-2024)
9.7.1 China Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production Growth Rate (2019-2024)
9.7.2 China Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production, Revenue, Price and Gross Margin (2019-2024)
10 Key Companies Profile
10.1 AstraZeneca
10.1.1 AstraZeneca Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Basic Information
10.1.2 AstraZeneca Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Overview
10.1.3 AstraZeneca Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Market Performance
10.1.4 AstraZeneca Business Overview
10.1.5 AstraZeneca Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs SWOT Analysis
10.1.6 AstraZeneca Recent Developments
10.2 Alexion
10.2.1 Alexion Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Basic Information
10.2.2 Alexion Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Overview
10.2.3 Alexion Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Market Performance
10.2.4 Alexion Business Overview
10.2.5 Alexion Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs SWOT Analysis
10.2.6 Alexion Recent Developments
10.3 Novartis
10.3.1 Novartis Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Basic Information
10.3.2 Novartis Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Overview
10.3.3 Novartis Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Market Performance
10.3.4 Novartis Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs SWOT Analysis
10.3.5 Novartis Business Overview
10.3.6 Novartis Recent Developments
10.4 Apellis Pharmaceuticals
10.4.1 Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Basic Information
10.4.2 Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Overview
10.4.3 Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Market Performance
10.4.4 Apellis Pharmaceuticals Business Overview
10.4.5 Apellis Pharmaceuticals Recent Developments
10.5 Roche
10.5.1 Roche Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Basic Information
10.5.2 Roche Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Overview
10.5.3 Roche Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Market Performance
10.5.4 Roche Business Overview
10.5.5 Roche Recent Developments
10.6 Amgen
10.6.1 Amgen Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Basic Information
10.6.2 Amgen Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Overview
10.6.3 Amgen Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Market Performance
10.6.4 Amgen Business Overview
10.6.5 Amgen Recent Developments
10.7 NovelMed
10.7.1 NovelMed Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Basic Information
10.7.2 NovelMed Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Overview
10.7.3 NovelMed Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Market Performance
10.7.4 NovelMed Business Overview
10.7.5 NovelMed Recent Developments
10.8 Chugai Pharmaceutical
10.8.1 Chugai Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Basic Information
10.8.2 Chugai Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Overview
10.8.3 Chugai Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Market Performance
10.8.4 Chugai Pharmaceutical Business Overview
10.8.5 Chugai Pharmaceutical Recent Developments
10.9 Akari Therapeutics
10.9.1 Akari Therapeutics Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Basic Information
10.9.2 Akari Therapeutics Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Overview
10.9.3 Akari Therapeutics Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Market Performance
10.9.4 Akari Therapeutics Business Overview
10.9.5 Akari Therapeutics Recent Developments
10.10 Omeros Corporation
10.10.1 Omeros Corporation Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Basic Information
10.10.2 Omeros Corporation Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Overview
10.10.3 Omeros Corporation Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Market Performance
10.10.4 Omeros Corporation Business Overview
10.10.5 Omeros Corporation Recent Developments
10.11 Regeneron Pharmaceuticals
10.11.1 Regeneron Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Basic Information
10.11.2 Regeneron Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Overview
10.11.3 Regeneron Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Market Performance
10.11.4 Regeneron Pharmaceuticals Business Overview
10.11.5 Regeneron Pharmaceuticals Recent Developments
11 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Forecast by Region
11.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast
11.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Region
11.2.4 South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs by Type (2025-2032)
12.1.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs by Type (2025-2032)
12.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Forecast by Application (2025-2032)
12.2.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (K MT) Forecast by Application
12.2.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Comparison by Region (M USD)
Table 5. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs as of 2022)
Table 10. Global Market Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Sites and Area Served
Table 12. Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Type
Table 13. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Challenges
Table 22. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Type (K MT)
Table 23. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Type (M USD)
Table 24. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (K MT) by Type (2019-2024)
Table 25. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Share by Type (2019-2024)
Table 28. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Price (USD/MT) by Type (2019-2024)
Table 29. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (K MT) by Application
Table 30. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Application
Table 31. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Application (2019-2024) & (K MT)
Table 32. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share by Application (2019-2024)
Table 35. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Region (2019-2024) & (K MT)
Table 37. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country (2019-2024) & (K MT)
Table 39. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Region (2019-2024) & (K MT)
Table 41. South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Region (2019-2024) & (K MT)
Table 43. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production (K MT) by Region (2019-2024)
Table 44. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Revenue Market Share by Region (2019-2024)
Table 46. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. AstraZeneca Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Basic Information
Table 52. AstraZeneca Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Overview
Table 53. AstraZeneca Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. AstraZeneca Business Overview
Table 55. AstraZeneca Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs SWOT Analysis
Table 56. AstraZeneca Recent Developments
Table 57. Alexion Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Basic Information
Table 58. Alexion Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Overview
Table 59. Alexion Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Alexion Business Overview
Table 61. Alexion Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs SWOT Analysis
Table 62. Alexion Recent Developments
Table 63. Novartis Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Basic Information
Table 64. Novartis Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Overview
Table 65. Novartis Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Novartis Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs SWOT Analysis
Table 67. Novartis Business Overview
Table 68. Novartis Recent Developments
Table 69. Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Basic Information
Table 70. Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Overview
Table 71. Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Apellis Pharmaceuticals Business Overview
Table 73. Apellis Pharmaceuticals Recent Developments
Table 74. Roche Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Basic Information
Table 75. Roche Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Overview
Table 76. Roche Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Roche Business Overview
Table 78. Roche Recent Developments
Table 79. Amgen Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Basic Information
Table 80. Amgen Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Overview
Table 81. Amgen Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Amgen Business Overview
Table 83. Amgen Recent Developments
Table 84. NovelMed Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Basic Information
Table 85. NovelMed Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Overview
Table 86. NovelMed Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. NovelMed Business Overview
Table 88. NovelMed Recent Developments
Table 89. Chugai Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Basic Information
Table 90. Chugai Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Overview
Table 91. Chugai Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Chugai Pharmaceutical Business Overview
Table 93. Chugai Pharmaceutical Recent Developments
Table 94. Akari Therapeutics Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Basic Information
Table 95. Akari Therapeutics Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Overview
Table 96. Akari Therapeutics Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Akari Therapeutics Business Overview
Table 98. Akari Therapeutics Recent Developments
Table 99. Omeros Corporation Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Basic Information
Table 100. Omeros Corporation Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Overview
Table 101. Omeros Corporation Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Omeros Corporation Business Overview
Table 103. Omeros Corporation Recent Developments
Table 104. Regeneron Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Basic Information
Table 105. Regeneron Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Overview
Table 106. Regeneron Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Regeneron Pharmaceuticals Business Overview
Table 108. Regeneron Pharmaceuticals Recent Developments
Table 109. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 110. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 111. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 112. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 113. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 114. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 115. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 116. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 117. South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 118. South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 119. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Consumption Forecast by Country (2025-2032) & (Units)
Table 120. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 121. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Forecast by Type (2025-2032) & (K MT)
Table 122. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Type (2025-2032) & (M USD)
Table 123. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Price Forecast by Type (2025-2032) & (USD/MT)
Table 124. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (K MT) Forecast by Application (2025-2032)
Table 125. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size (M USD), 2019-2032
Figure 5. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size (M USD) (2019-2032)
Figure 6. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Country (M USD)
Figure 11. Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Revenue Share by Manufacturers in 2023
Figure 13. Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share by Type
Figure 18. Sales Market Share of Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs by Type in 2023
Figure 20. Market Size Share of Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share by Application
Figure 24. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share by Application in 2023
Figure 26. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share by Application (2019-2024)
Figure 27. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share by Application in 2023
Figure 28. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share by Country in 2023
Figure 37. Germany Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share by Region in 2023
Figure 44. China Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (K MT)
Figure 50. South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production Market Share by Region (2019-2024)
Figure 62. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production (K MT) Growth Rate (2019-2024)
Figure 65. China Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share Forecast by Type (2025-2032)
Figure 70. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Forecast by Application (2025-2032)
Figure 71. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share Forecast by Application (2025-2032)
